Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Activist investor plans second fight at Masimo, sending shares up 12%
10:01am, Monday, 25'th Mar 2024
Quentin Koffey's Politan Capital waged a successful proxy fight at Masimo last year, and it is now seeking two more board seats.
Masimo's stock rallies on report of looming activist campaign, disclosure of spinoff plan
06:46am, Monday, 25'th Mar 2024
Masimo Corp.'s stock MASI, +1.40% was up 12% in premarket trading on Monday after The Wall Street Journal reported that activist investor Politan Capital Management plans to nominate two more members
Masimo Stock Surges After Proposed Spinoff of Consumer Business
10:45pm, Sunday, 24'th Mar 2024
Share in Masimo (MASI) surged 13% in extended trading on Friday after the company announced that it is planning a spinoff of its consumer unit to improve the profitability of its primary healthcare bu
Activist investor Politan plans second proxy battle at Masimo, WSJ reports
08:18pm, Sunday, 24'th Mar 2024
Activist investor Politan Capital Management, which last year won two seats on the board of medical technology company Masimo Corp , is planning a second proxy battle for two more seats, the Wall Stre
Masimo plans to spinoff consumer business
05:56pm, Friday, 22'nd Mar 2024
Medical technology company Masimo Corp said on Friday it is evaluating a proposed spinoff of its consumer business, which includes its consumer health and audio products, sending shares up 13% in exte
Here's Why You Should Add Masimo (MASI) to Your Portfolio Now
09:01am, Tuesday, 19'th Mar 2024
Masimo's (MASI) R&D activities raise optimism about the stock.
Is Masimo (MASI) Outperforming Other Medical Stocks This Year?
10:46am, Monday, 11'th Mar 2024
Here is how Masimo (MASI) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
08:30am, Monday, 04'th Mar 2024
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 202
Masimo (MASI) Q4 Earnings Beat Estimates, Margins Decline
10:06am, Wednesday, 28'th Feb 2024
Despite strength in the Hearables category, Masimo's (MASI) overall fourth-quarter results reflect soft performances.
Masimo (MASI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Tuesday, 27'th Feb 2024
The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Masimo (MASI) Beats Q4 Earnings and Revenue Estimates
07:01pm, Tuesday, 27'th Feb 2024
Masimo (MASI) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $1.32 per share a year ago.
Are Medical Stocks Lagging Masimo (MASI) This Year?
10:46am, Friday, 23'rd Feb 2024
Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.
Masimo (MASI), UCHealth Unite to Improve Care With Telehealth
10:46am, Wednesday, 21'st Feb 2024
Masimo (MASI) collaborates with UCHealth to boost patient care by combining its latest virtual care technologies with UCHealth's clinical expertise and telehealth innovations.
Masimo Corporation: Logical Expansion To Leverage Its Existing Portfolio
05:30am, Wednesday, 21'st Feb 2024
Masimo's core segment in Professional Healthcare could have support into a multi-year growth based on current growth of Unrecognized Contract Value growth. Expansion into the consumer space is a logic
Earnings Preview: Masimo (MASI) Q4 Earnings Expected to Decline
11:06am, Tuesday, 20'th Feb 2024
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
